ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial
DiscussionAspirin may prevent colorectal cancer through multiple, interrelated mechanisms. The ASPIRED trial will scrutinize these pathways and investigate putative mechanistically based risk-stratification biomarkers.Trial registrationThis protocol is registered with the U.S. National Institutes of Health trial registry, ClinicalTrials.gov, under the identifierNCT02394769. Registered on  16 March 2015. (Source: Trials)
Source: Trials - January 31, 2017 Category: Research Source Type: clinical trials

Tailored Transition for IBD Adolescents
Condition:   Inflammatory Bowel Disease Intervention:   Procedure: Radiologic (MRE) or endoscopic (sigmoidoscopy) evaluation Sponsor:   Schneider Children's Medical Center, Israel Not yet recruiting - verified September 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2016 Category: Research Source Type: clinical trials